New Inhaler for COPDers – a miracle? PATHOS Study

Ask your doctor…and look for a miracle inhaler for some COPDers.  The PATHOS study published in the Journal of Internal Medicine shows that SYMBICORTR TurbuhalerR (budesonide/formoterol) must be some kind of miracle inhaler for chronic obstructive pulmonary disease (COPD) patients. 

Among other advantages, the PATHOS study showed a 26% decrease in exacerbations for moderate – severe COPD!  The Symbicort    SYMBICORTR TurbuhalerR            inhaler has to be bliss for those COPDers able to use it.   

I’ve used Foradil Aerolizer (Formoterol Fumarate Inhalation Powder) for years.  The Fulmarate ingredient seems to make it a relative of Symbicort        SYMBICORTR TurbuhalerR                and it is the single inhaler I take (of three) that noticeably helps me breathe easier.

Best of all is the promise shown in the PATHOS study:

“Dr. Kjell Larsson, Professor of Respiratory Medicine at the Karolinska

Institute in Stockholm said: “So called ‘real world’ studies, such as

PATHOS, together with randomised prospective studies, play an important role

in answering questions about the value of medicines in delivering better,

cost-effective healthcare to patients. These findings can help physicians

and the healthcare community to understand disease patterns and create a

fuller picture of treatment effects and what patients are experiencing.”

The only side-affect/warning I can find  might be for asthma patients.

http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=77788

http://www.4-traders.com/ASTRAZENECA-PLC-4000930/news/AstraZeneca-plc-Real-w

orld-study-comparing-commonly-prescribed-COPD-medicines-shows-choice-of-trea

-16558063/ …thanks to Linda W EFFORTS <www.emphysema.net> 

Thanks for listening … Sharon O’Hara < familien1@comcast.net

Spring 2013

p class=”MsoNormal”